Ozanezumab dose selection for amyotrophic lateral sclerosis by pharmacokinetic-pharmacodynamic modelling of immunohistochemistry data from patient muscle biopsies
about
Ozanezumab dose selection for amyotrophic lateral sclerosis by pharmacokinetic-pharmacodynamic modelling of immunohistochemistry data from patient muscle biopsies
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Ozanezumab dose selection for ...... a from patient muscle biopsies
@ast
Ozanezumab dose selection for ...... a from patient muscle biopsies
@en
Ozanezumab dose selection for ...... a from patient muscle biopsies
@nl
type
label
Ozanezumab dose selection for ...... a from patient muscle biopsies
@ast
Ozanezumab dose selection for ...... a from patient muscle biopsies
@en
Ozanezumab dose selection for ...... a from patient muscle biopsies
@nl
prefLabel
Ozanezumab dose selection for ...... a from patient muscle biopsies
@ast
Ozanezumab dose selection for ...... a from patient muscle biopsies
@en
Ozanezumab dose selection for ...... a from patient muscle biopsies
@nl
P2093
P2860
P921
P1433
P1476
Ozanezumab dose selection for ...... a from patient muscle biopsies
@en
P2093
Alienor Berges
David Krull
Jonathan Bullman
Nicola Williams
Stewart Bates
P2860
P304
P356
10.1371/JOURNAL.PONE.0117355
P407
P577
2015-01-01T00:00:00Z